Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Patterson

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|December 14, 2004
Proteomics: beginning to realize its promise?Scott D Patterson
Nature Biotechnology|March 1, 2003
Data analysis--the Achilles heel of proteomicsScott D Patterson
Biotechniques|November 23, 2023
Decoding disease: Scott Patterson's perspectives on the power of biomarkers in drug developmentScott D Patterson
Biotechniques|September 30, 2003
Proteomics: evolution of the technologyScott D Patterson
Pharmaceutical Statistics|December 14, 2011
Viewpoint: observations on scaled average bioequivalenceScott D Patterson, Byron Jones
Pharmaceutical Statistics|April 23, 2008
Literature review: January-March 2008Scott D Patterson, Kevin Carroll
Pharmaceutical Statistics|May 4, 2007
A brief review of Phase 1 and Clinical Pharmacology statistics in clinical drug developmentScott D Patterson, Byron Jones
Expert Opinion on Drug Discovery|March 19, 2013
The role of biomarkers in the future of drug developmentScott D Patterson, Robert F Dubose
Trends in Biotechnology|February 7, 2003
Proteomics: drug target discovery on an industrial scaleTerence E Ryan, Scott D Patterson
Journal of the National Cancer Institute. Monographs|June 16, 2011
The value of banked samples for oncology drug discovery and developmentPeter M Shaw, Scott D Patterson
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|December 14, 2004
Proteomics: beginning to realize its promise?Scott D Patterson
Nature Biotechnology|March 1, 2003
Data analysis--the Achilles heel of proteomicsScott D Patterson
Biotechniques|November 23, 2023
Decoding disease: Scott Patterson's perspectives on the power of biomarkers in drug developmentScott D Patterson
Biotechniques|September 30, 2003
Proteomics: evolution of the technologyScott D Patterson
Pharmaceutical Statistics|December 14, 2011
Viewpoint: observations on scaled average bioequivalenceScott D Patterson, Byron Jones
Pharmaceutical Statistics|April 23, 2008
Literature review: January-March 2008Scott D Patterson, Kevin Carroll
Pharmaceutical Statistics|May 4, 2007
A brief review of Phase 1 and Clinical Pharmacology statistics in clinical drug developmentScott D Patterson, Byron Jones
Expert Opinion on Drug Discovery|March 19, 2013
The role of biomarkers in the future of drug developmentScott D Patterson, Robert F Dubose
Trends in Biotechnology|February 7, 2003
Proteomics: drug target discovery on an industrial scaleTerence E Ryan, Scott D Patterson
Journal of the National Cancer Institute. Monographs|June 16, 2011
The value of banked samples for oncology drug discovery and developmentPeter M Shaw, Scott D Patterson
Pageof 6